TOKYO--(BUSINESS WIRE)--Elix, Inc., an AI drug discovery company with the mission of “Rethinking Drug Discovery” (CEO: Shinya Yuki/Headquarters: Tokyo; hereafter referred to as "Elix") commenced joint ...
Elix Inc. has teamed up with Shionogi & Co. Ltd. to validate a retrosynthetic analysis model for drug discovery that will employ chemical reaction data from Shionogi to explore various routes to ...
Pattern mapping is a synthetic tactic that is complementary to standard retrosynthetic analysis. When combined with the concept of traceless stereochemical guidance, it leads to an efficient synthesis ...
Optibrium™, a developer of software for drug discovery, announced a collaboration with InfoChem GmbH, a leader in cheminformatics. The collaboration provides StarDrop™ users with easy access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results